vated QT interval variability is a predictor of malignant ventricular arrhythmia, but the underlying mechanisms are incompletely understood. A recent study in dogs with pacing-induced heart failure suggests that QT variability is linked to cardiac sympathetic nerve activity. The aim of this study was to determine whether increased cardiac sympathetic activity is associated with increased beat-to-beat QT interval variability in patients with essential hypertension. We recorded resting norepinephrine (NE) spillover into the coronary sinus and single-lead, short-term, high-resolution, body-surface ECG in 23 patients with essential hypertension and 9 normotensive control subjects. To assess beat-to-beat QT interval variability, we calculated the overall QT variability (QTVN) as well as the QT variability index (QTVi). Cardiac NE spillover (12.2 Ϯ 6.5 vs. 20.7 Ϯ 14.7, P ϭ 0.03) and QTVi (Ϫ1.75 Ϯ 0.36 vs. Ϫ1.42 Ϯ 0.50, P ϭ 0.05) were significantly increased in hypertensive patients compared with normotensive subjects. QTVN was significantly correlated with cardiac NE spillover (r 2 ϭ 0.31, P ϭ 0.001), with RR variability (r 2 ϭ 0.20, P ϭ 0.008), and with systolic blood pressure (r 2 ϭ 0.16, P ϭ 0.02). Linear regression analysis identified the former two as independent predictors of QTVN. In conclusion, elevated repolarization lability is directly associated with sympathetic cardiac activation in patients with essential hypertension. norepinephrine spillover THE QT INTERVAL OF THE BODY surface ECG reflects global depolarization and repolarization in the ventricular myocardium and undergoes subtle beat-to-beat fluctuations (9). Elevated beat-to-beat QT interval variability has been demonstrated in various cardiac (6, 26) but also noncardiac conditions (4, 36). Importantly, QT variability has been shown to be elevated in dogs before pharmacologically induced Torsades de Pointes (32, 34) and in patients with structural heart disease before ventricular tachycardia/ventricular fibrillation events (33). Furthermore, QT variability was associated with an increased risk of ventricular tachycardia/ventricular fibrillation in patients enrolled in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II (17) and was predictive of sudden cardiac death in patients with asymptomatic chronic heart failure with mild to moderate left ventricular (LV) diastolic dysfunction (27). However, the mechanisms contributing to beat-to-beat QT interval variability are incompletely understood. Besides electrical restitution, which reflects the intrinsic adaptation of the action potential duration to changes in cycle length (14), the autonomic nervous system is thought to play a key role in the genesis of beat-to-beat QT interval variability. Previous studies addressing this issue have provided conflicting results. A recent study in dogs showed that QT variability was related to left stellate-ganglion activity, but only after the dogs had developed heart failure (28). In healthy humans, pharmacological activation or blockade of -adren...